PKCζ mediates breakdown of outer blood-retinal barriers in diabetic retinopathy

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Omri, Samy ^a,b,c   Behar Cohen, Francine ^a,b,c,d   Rothschild, Pierre Raphaël ^a,b,c,d   Gélizé, Emmanuelle ^a,b,c,d   Jonet, Laurent ^a,b,c   Jeanny, Jean Claude ^a,b,c   Omri, Boubaker ^a,b,c   Crisanti, Patricia ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C ZETA; CARRIER PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PAR-3 PROTEIN, RAT; PAR6 PROTEIN, RAT; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD RETINA BARRIER; CELL DEATH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIABETIC RETINOPATHY; HYPERGLYCEMIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LASER MICRODISSECTION; NICK END LABELING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHOTORECEPTOR INNER SEGMENT; PHOTORECEPTOR OUTER SEGMENT; PIGMENT EPITHELIUM; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; RETINA CONE; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MEMBRANE; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHOTORECEPTOR CELL; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

ANIMALS; BLOOD-RETINAL BARRIER; CARRIER PROTEINS; CELL MEMBRANE; DIABETIC RETINOPATHY; HYPERGLYCEMIA; NF-KAPPA B; PHOTORECEPTOR CELLS, VERTEBRATE; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS;

EID: 84896713212     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081600     Document Type: Article

References (39)

1. Fong DS, Aiello LP, Ferris FL, Klein R (2004) Diabetic retinopathy. Diabetes Care 27: 2540-2553. (Pubitemid 39281419)
2. Congdon NG, Friedman DS, Lietman T (2003) Important causes of visual impairment in the world today. JAMA 290: 2057-2060. (Pubitemid 37430590)
3. Gardner TW, Antonetti DA (2008) Novel potential mechanisms for diabetic macular edema: leveraging new investigational approaches. Curr Diab Rep 8: 263-269.
4. Miyamoto N, de Kozak Y, Normand N, Courtois Y, Jeanny JC, et al. (2008) PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema. Ophthalmic Res. Switzerland: 2008 S. Karger AG, Basel. pp. 203-207.
5. Simo R, Villarroel M, Corraliza L, Hernandez C, Garcia-Ramirez M (2010) The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier-implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010: 190724.
6. Omri S, Omri B, Savoldelli M, Jonet L, Thillaye-Goldenberg B, et al. (2010) The outer limiting membrane (OLM) revisited: clinical implications. Clin Ophthalmol 4: 183-195.
7. Henrique D, Schweisguth F (2003) Cell polarity: the ups and downs of the Par6/aPKC complex. Curr Opin Genet Dev. England. pp. 341-350.
8. Hurd TW, Margolis B (2005) Pars and polarity: taking control of Rac. Nat Cell Biol. England. pp. 205-207.
9. Shin K, Fogg VC, Margolis B (2006) Tight junctions and cell polarity. Annu Rev Cell Dev Biol 22: 207-235.
10. Helfrich I, Schmitz A, Zigrino P, Michels C, Haase I, et al. (2007) Role of aPKC isoforms and their binding partners Par3 and Par6 in epidermal barrier formation. J Invest Dermatol. United States. pp. 782-791.
11. Lin D, Edwards AS, Fawcett JP, Mbamalu G, Scott JD, et al. (2000) A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC signalling and cell polarity. Nat Cell Biol 2: 540-547.
12. Suzuki A, Ishiyama C, Hashiba K, Shimizu M, Ebnet K, et al. (2002) aPKC kinase activity is required for the asymmetric differentiation of the premature junctional complex during epithelial cell polarization. J Cell Sci 115: 3565-3573.
13. Ohno S (2001) Intercellular junctions and cellular polarity: the PAR-aPKC complex, a conserved core cassette playing fundamental roles in cell polarity. Curr Opin Cell Biol. United States. pp. 641-648.
14. Suzuki A, Ohno S (2006) The PAR-aPKC system: lessons in polarity. J Cell Sci. England. pp. 979-987.
15. Jain S, Suzuki T, Seth A, Samak G, Rao R (2011) Protein kinase Czeta phosphorylates occludin and promotes assembly of epithelial tight junctions. Biochem J. England. pp. 289-299.
16. Xia L, Wang H, Munk S, Kwan J, Goldberg HJ, et al. (2008) High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells. Am J Physiol Renal Physiol 295: F1705-1714.
17. Steiler TL, Galuska D, Leng Y, Chibalin AV, Gilbert M, et al. (2003) Effect of hyperglycemia on signal transduction in skeletal muscle from diabetic Goto-Kakizaki rats. Endocrinology 144: 5259-5267. (Pubitemid 37476054)
18. Burbach GJ, Dehn D, Nagel B, Del Turco D, Deller T (2004) Laser microdissection of immunolabeled astrocytes allows quantification of astrocytic gene expression. J Neurosci Methods. Netherlands. pp. 141-148.
19. Crisanti P, Laplace O, Lecain E, Jonet L, Jeanny JC, et al. (2006) The role of PKCzeta in NMDA-induced retinal ganglion cell death: prevention by aspirin. Apoptosis 11: 983-991. (Pubitemid 43876828)
20. de Kozak Y, Omri B, Smith JR, Naud MC, Thillaye-Goldenberg B, et al. (2007) Protein kinase Czeta (PKCzeta) regulates ocular inflammation and apoptosis in endotoxin-induced uveitis (EIU): signaling molecules involved in EIU resolution by PKCzeta inhibitor and interleukin-13. Am J Pathol. United States. pp. 1241-1257.
21. Liang H, Baudouin C, Behar-Cohen F, Crisanti P, Omri B (2007) Protein kinase C-zeta mediates retinal degeneration in response to TNF. J Neuroimmunol. Netherlands. pp. 104-110.
22. Adams AJ, Zisman F, Ai E, Bresnick G (1987) Macular edema reduces B cone sensitivity in diabetics. Appl Opt. United States. pp. 1455-1457.
23. Yamamoto S, Kamiyama M, Nitta K, Yamada T, Hayasaka S (1996) Selective reduction of the S cone electroretinogram in diabetes. Br J Ophthalmol 80: 973-975. (Pubitemid 26413699)
24. Cho NC, Poulsen GL, Ver Hoeve JN, Nork TM (2000) Selective loss of S-cones in diabetic retinopathy. Arch Ophthalmol. United States. pp. 1393-1400.
25. Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Prog Retin Eye Res. England: 2011 Elsevier Ltd. pp. 343-358.
26. Xu HZ, Le YZ (2011) Significance of outer blood-retina barrier breakdown in diabetes and ischemia. Invest Ophthalmol Vis Sci 52: 2160-2164.
27. Xu HZ, Song Z, Fu S, Zhu M, Le YZ (2011) RPE barrier breakdown in diabetic retinopathy: seeing is believing. J Ocul Biol Dis Infor 4: 83-92.
28. Ghalayini AJ, Koutz CA, Wetsel WC, Hannun YA, Anderson RE (1994) Immunolocalization of PKC zeta in rat photoreceptor inner segments. Curr Eye Res 13: 145-150. (Pubitemid 24078012)
29. Lee A, Jimenez A, Cui G, Haeseleer F (2007) Phosphorylation of the Ca2+- binding protein CaBP4 by protein kinase C zeta in photoreceptors. J Neurosci 27: 12743-12754. (Pubitemid 350127811)
30. Aveleira CA, Lin CM, Abcouwer SF, Ambrosio AF, Antonetti DA (2010) TNF-alpha signals through PKCzeta/NF-kappaB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes. United States. pp. 2872-2882.
31. Titchenell PM, Lin CM, Keil JM, Sundstrom JM, Smith CD, et al. (2012) Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction. Biochem J. England. pp. 455-467.
32. Willis CL, Meske DS, Davis TP (2010) Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab. United States. pp. 1847-1859.
33. Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, et al. (2009) Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58: 337-343.
34. Wang YM, Seibenhener ML, Vandenplas ML, Wooten MW (1999) Atypical PKC zeta is activated by ceramide, resulting in coactivation of NF-kappaB/JNK kinase and cell survival. J Neurosci Res 55: 293-302. (Pubitemid 29055179)
35. Bieberich E (2008) Ceramide signaling in cancer and stem cells. Future Lipidol 3: 273-300.
36. Müller G, Ayoub M, Storz P, Rennecke J, Fabbro D, et al. (1995) PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14: 1961-1969.
37. Macdonald NJ, Perez-Polo JR, Bennett AD, Taglialatela G (1999) NGF-resistant PC12 cell death induced by arachidonic acid is accompanied by a decrease of active PKC zeta and nuclear factor kappa B. J Neurosci Res 57: 219-226. (Pubitemid 29300324)
38. Sato T, Kageura T, Hashizume T, Hayama M, Kitatani K, et al. (1999) Stimulation by ceramide of phospholipase A2 activation through a mechanism related to the phospholipase C-initiated signaling pathway in rabbit platelets. J Biochem 125: 96-102. (Pubitemid 29085968)
39. Omri S, Behar-Cohen F, de Kozak Y, Sennlaub F, Verissimo LM, et al. (2011) Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCzeta in the Goto Kakizaki rat model. Am J Pathol. United States: 2011 American Society for Investigative Pathology. Published by Elsevier Inc. pp. 942-953.